Amplitude Healthcare Acquisition Corporation's latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 5 Aug 2026Directors make major business decisions; 75% shareholder turnout shows strong investor engagement.
Contingent payments reward future drug approvals, affecting company value and cash needs.
Merger changes ownership structure dramatically; original shareholders drop from 11.27% to 6.68% of company.
Major merger and funding deal creates new company ownership structure and future obligations.
Delisting risk means stock could disappear from major exchange; company has until November 2026 to recover.
Company exploring options to boost shareholder value after stock price decline.
Board member departures and replacements affect company leadership and oversight.
Stocky reads Amplitude Healthcare Acquisition Corporation's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Amplitude Healthcare Acquisition Corporation's most recent tracked filing was a 8-K on 3 Aug 2026: Stockholders elect two directors at annual meeting.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.